Small-Molecule Drug Discovery
We work with clients to move their discovery projects forward to key milestones or value inflection points. This includes:
- Identifying new hit and lead molecules for early-stage projects
- Optimising lead series and delivering preclinical candidate molecules
- Tailoring the approach towards oral, intravenous or inhaled administration and optimising for CNS penetration or exclusion